Cardiovascular Toxicities Associated With Loperamide: Analysis of the World Health Organization Pharmacovigilance Database

Circulation. 2021 Jan 26;143(4):403-405. doi: 10.1161/CIRCULATIONAHA.120.050587. Epub 2021 Jan 25.

Pierre Ollitrault^{1

2}, Charles Dolladille^{3

2}, Basile Chrétien^{3

4

2}, Paul Milliez^{1

2}, Joachim Alexandre^{3

4

2}

¹ Electrophysiology Unit, Department of Cardiology (P.O., P.M.), Caen University Hospital, France.
² Université Caen Normandie, France (P.O., C.D., B.C., P.M., J.A.).
³ Pharmacoepidemiology Unit, Department of Pharmacology (C.D., B.C., J.A.), Caen University Hospital, France.
⁴ EA 4650, Signalisation, Électrophysiologie et Imagerie des Lésions d'Ischémie-Reperfusion Myocardique, Normandie University (C.D., B.C., J.A.), Caen University Hospital, France.

No abstract available

Keywords: drug-related side effects and adverse reactions; loperamide; pharmacovigilance; toxicity.

Publication types